1. Biochemistry and Chemical Biology
  2. Neuroscience

Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor

  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose  Is a corresponding author
  1. The University of Tokyo, Japan
  2. Nihon University School of Medicine, Japan
https://doi.org/10.7554/eLife.57544
Share this article
Cite this article
  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose
(2020)
Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor
eLife 9:e57544.
https://doi.org/10.7554/eLife.57544
  2. Download BibTeX
  3. Download .RIS

Abstract

Adenosine 5' triphosphate (ATP) is a ubiquitous extracellular signaling messenger. Here, we describe a method for in-vivo imaging of extracellular ATP with high spatiotemporal resolution. We prepared a comprehensive set of cysteine-substitution mutants of ATP-binding protein, Bacillus FoF1-ATP synthase e subunit, labeled with small-molecule fluorophores at the introduced cysteine residue. Screening revealed that the Cy3-labeled glutamine-105 mutant (Q105C-Cy3; designated ATPOS) shows a large fluorescence change in the presence of ATP, with submicromolar affinity, pH-independence, and high selectivity for ATP over ATP metabolites and other nucleotides. To enable in-vivo validation, we introduced BoNT/C-Hc for binding to neuronal plasma membrane and Alexa Fluor 488 for ratiometric measurement. The resulting ATPOS complex binds to neurons in cerebral cortex of living mice, and clearly visualized a concentrically propagating wave of extracellular ATP release in response to electrical stimulation. ATPOS should be useful to probe the extracellular ATP dynamics of diverse biological processes in vivo.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nami Kitajima

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9838-832X

  2. Kenji Takikawa

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  3. Hiroshi Sekiya

    Department of Physiology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  4. Kaname Satoh

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  5. Daisuke Asanuma

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  6. Hirokazu Sakamoto

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  7. Shodai Takahashi

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  8. Kenjiro Hanaoka

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0797-4038

  9. Yasuteru Urano

    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  10. Shigeyuki Namiki

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    Competing interests
    The authors declare that no competing interests exist.

  11. Masamitsu Iino

    Cellular and Molecular Pharmacology, Nihon University School of Medicine, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6426-4206

  12. Kenzo Hirose

    Department of Pharmacology, The University of Tokyo, Bunkyo-ku, Japan
    For correspondence
    kenzoh@m.u-tokyo.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8944-6513

Funding

Ministry of Education, Culture, Sports, Science, and Technology (17H04029)

  • Kenzo Hirose

Ministry of Education, Culture, Sports, Science, and Technology (17K08584)

  • Shigeyuki Namiki

Japan Science and Technology Agency (JPMJPR17P1)

  • Daisuke Asanuma

Takeda Science Foundation

  • Nami Kitajima

Ministry of Education, Culture, Sports, Science, and Technology (19K22247)

  • Kenzo Hirose

Ministry of Education, Culture, Sports, Science, and Technology (25221304)

  • Masamitsu Iino

Ministry of Education, Culture, Sports, Science, and Technology (18K14915)

  • Hiroshi Sekiya

Ministry of Education, Culture, Sports, Science, and Technology (17H04764)

  • Daisuke Asanuma

Ministry of Education, Culture, Sports, Science, and Technology (18H04726)

  • Daisuke Asanuma

Ministry of Education, Culture, Sports, Science, and Technology (19K16251)

  • Hirokazu Sakamoto

Ministry of Education, Culture, Sports, Science, and Technology (18H04609)

  • Kenjiro Hanaoka

Ministry of Education, Culture, Sports, Science, and Technology (19H05414)

  • Kenjiro Hanaoka

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Yamuna Krishnan, University of Chicago, United States

Ethics

Animal experimentation: All procedures used in animal experiments were in accordance with the guidelines established by the Animal Welfare Committee of the University of Tokyo (Medicine-P10-010, Medicine-P15-017 and Medicine-P19-092).

Version history

  1. Received: April 3, 2020
  2. Accepted: July 9, 2020
  3. Accepted Manuscript published: July 10, 2020 (version 1)
  4. Version of Record published: August 3, 2020 (version 2)

Copyright

© 2020, Kitajima et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,118
    views
  • 1,139
    downloads
  • 38
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nami Kitajima
  2. Kenji Takikawa
  3. Hiroshi Sekiya
  4. Kaname Satoh
  5. Daisuke Asanuma
  6. Hirokazu Sakamoto
  7. Shodai Takahashi
  8. Kenjiro Hanaoka
  9. Yasuteru Urano
  10. Shigeyuki Namiki
  11. Masamitsu Iino
  12. Kenzo Hirose
(2020)
Real-time in vivo imaging of extracellular ATP in the brain with a hybrid-type fluorescent sensor
eLife 9:e57544.
https://doi.org/10.7554/eLife.57544

Share this article

https://doi.org/10.7554/eLife.57544

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    MEMO1 binds iron and modulates iron homeostasis in cancer cells

    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article Updated

    Mediator of ERBB2-driven cell motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high-MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus

    Natalia E Ketaren, Fred D Mast ... John D Aitchison
    Research Advance

    To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to previous variants poses a significant challenge. A compelling new therapeutic strategy against SARS-CoV-2 is that of single-domain antibodies, termed nanobodies, which address certain limitations of monoclonal antibodies. Here, we demonstrate that our high-affinity nanobody repertoire, generated against wild-type SARS-CoV-2 spike protein (Mast et al., 2021), remains effective against variants of concern, including omicron BA.4/BA.5; a subset is predicted to counter resistance in emerging XBB and BQ.1.1 sublineages. Furthermore, we reveal the synergistic potential of nanobody cocktails in neutralizing emerging variants. Our study highlights the power of nanobody technology as a versatile therapeutic and diagnostic tool to combat rapidly evolving infectious diseases such as SARS-CoV-2.

    1. Biochemistry and Chemical Biology

    Molecular dissection of PI3Kβ synergistic activation by receptor tyrosine kinases, GβGγ, and Rho-family GTPases

    Benjamin R Duewell, Naomi E Wilson ... Scott D Hansen
    Research Article

    Phosphoinositide 3-kinase (PI3K) beta (PI3Kβ) is functionally unique in the ability to integrate signals derived from receptor tyrosine kinases (RTKs), G-protein coupled receptors, and Rho-family GTPases. The mechanism by which PI3Kβ prioritizes interactions with various membrane-tethered signaling inputs, however, remains unclear. Previous experiments did not determine whether interactions with membrane-tethered proteins primarily control PI3Kβ localization versus directly modulate lipid kinase activity. To address this gap in our knowledge, we established an assay to directly visualize how three distinct protein interactions regulate PI3Kβ when presented to the kinase in a biologically relevant configuration on supported lipid bilayers. Using single molecule Total Internal Reflection Fluorescence (TIRF) Microscopy, we determined the mechanism controlling PI3Kβ membrane localization, prioritization of signaling inputs, and lipid kinase activation. We find that auto-inhibited PI3Kβ prioritizes interactions with RTK-derived tyrosine phosphorylated (pY) peptides before engaging either GβGγ or Rac1(GTP). Although pY peptides strongly localize PI3Kβ to membranes, stimulation of lipid kinase activity is modest. In the presence of either pY/GβGγ or pY/Rac1(GTP), PI3Kβ activity is dramatically enhanced beyond what can be explained by simply increasing membrane localization. Instead, PI3Kβ is synergistically activated by pY/GβGγ and pY/Rac1 (GTP) through a mechanism consistent with allosteric regulation.